Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco | Zendy

Mohammed Elmzibri | Zendy; Imane Chaoui | Zendy; Radia Sabouni | Zendy; Moussa Kourout | Zendy; A. Jordaan | Zendy; Ouafae Lahlou | Zendy; Rajae Elouad | Zendy; Mohammed Akrim | Zendy; Thomas C. Victor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco

Author(s) -

Mohammed Elmzibri,

Imane Chaoui,

Radia Sabouni,

Moussa Kourout,

A. Jordaan,

Ouafae Lahlou,

Rajae Elouad,

Mohammed Akrim,

Thomas C. Victor

Publication year - 2009

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.125

Subject(s) - ethambutol , isoniazid , mycobacterium tuberculosis , streptomycin , inha , tuberculosis , biology , rifampicin , microbiology and biotechnology , drug resistance , genotype , mycobacterium tuberculosis complex , virology , gene , medicine , genetics , antibiotics , pathology

Drug-resistant tuberculosis is a major problem worldwide. Based on the knowledge of specific mutations occurring in Mycobacterium tuberculosis genome, drug resistance can be detected earlier. The aim of this study was to determine the prevalence of the most common mutations associated with resistance to Isoniazid (INH), Streptomycin (SM) and Ethambutol (EMB) in Mycobacterium tuberculosis isolates from Morocco in order to select target mutations to develop tests for rapid detection of drug-resistant Mycobacterium tuberculosis Moroccan isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research